Treatment of prostatic cancer. Newer forms of androgen deprivation

M. S. Soloway

Research output: Contribution to journalArticle

Abstract

The hope of providing a safe alternative to bilateral orchiectomy for patients with prostatic cancer has spurred the development in recent years of various agents capable of reducing androgen level. Another reason for intensifying these efforts relates to the hope held by many clinicians that earlier initiation of androgen deprivation for patients with regional or distant metastases will improve the patient's course. Finally, attempts to provide a more complete androgen blockade hold the hope of delaying or preventing relapse, which usually occurs with continued androgen deprivation.

Original languageEnglish (US)
Pages (from-to)249-258
Number of pages10
JournalPostgraduate medicine
Volume80
Issue number1
DOIs
StatePublished - Jan 1 1986

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this